
EUSA Pharma
Pharmaceutical company developing and licensing late-stage oncology, pain control, and critical care products.
Date | Investors | Amount | Round |
---|---|---|---|
- | investor investor investor investor investor investor investor investor investor investor investor | €0.0 | round |
investor investor | €0.0 | round | |
investor investor investor investor | €0.0 | round | |
N/A | €0.0 | round | |
N/A | €0.0 | round | |
N/A | €0.0 | round | |
investor investor | €0.0 | round | |
$680m | Acquisition | ||
Total Funding | 000k |

















GBP | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|---|---|
Revenues | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
% growth | 16 % | 79 % | 66 % | 29 % | 106 % | (20 %) | 8 % |
EBITDA | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
% EBITDA margin | - | 5 % | 79 % | (1 %) | 18 % | 24 % | 12 % |
Profit | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
% profit margin | (26 %) | (20 %) | 48 % | (32 %) | 5 % | 4 % | (3 %) |
EV | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
EV / revenue | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
EV / EBITDA | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
R&D budget | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
Source: Company filings or news article
Related Content
EUSA Pharma is a dynamic, global specialty pharmaceutical company focused on developing and commercializing innovative medicines for oncology and rare diseases. The company serves patients worldwide, aiming to make a meaningful difference in their lives by providing access to life-changing treatments. EUSA Pharma operates in the pharmaceutical market, targeting both healthcare professionals and patients who require specialized therapies. The business model revolves around research and development, clinical trials, regulatory approvals, and the commercialization of its products. Revenue is generated through the sale of its pharmaceutical products, which are distributed globally. The company is committed to expanding its product portfolio and reaching more patients in need.
Keywords: oncology, rare diseases, innovative medicines, global distribution, clinical trials, regulatory approvals, patient-focused, specialty pharmaceuticals, healthcare professionals, life-changing treatments.
Tech stack
Investments by EUSA Pharma
Edit